- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Natco Pharma Limited — Updates, 09-10-2025: Press Release
09-10-2025 | 05:32 pm
09-10-2025 | 05:32 pm
NATCO Pharma can now launch its generic Risdiplam for Spinal Muscular Atrophy (SMA) after a court upheld its right against Roche's appeal. This enables an affordable drug (INR 15,900 MRP) for Indian patients, opening a new market for NATCO.
No comments yet. Be the first to comment!